divislab glp-1 novo nordisk Details of failed studies cast pall on Nordisk's as Alzheimer's treatment Novo asks FDA to prevent

Understanding what triggers lightheadedness helps you stay safe while your body adjusts to treatment

Miracle weight loss medication like Ozempic have taken the world by storm but are we reaching out to the needle too soon?

Challenges with GLP-1 Therapy: Many users experience energy dips, muscle loss, and nutrient deficiencies while on GLP-1 therapies like semaglutide

Try this 10-min healthy egg breakfast with ricotta, almonds, olive oil

In the past seven years, the proportion of new, commercial patients who are rejected for a launch brand increased from 37% to 56%, such that more than half of the attempts to initiate a new treatment in 2022 were unfilled the first year